8-144516029-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001413041.1(RECQL4):c.-44G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000799 in 1,611,570 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00046 ( 2 hom. )
Consequence
RECQL4
NM_001413041.1 5_prime_UTR_premature_start_codon_gain
NM_001413041.1 5_prime_UTR_premature_start_codon_gain
Scores
1
9
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0054152906).
BP6
Variant 8-144516029-C-T is Benign according to our data. Variant chr8-144516029-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 135166.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-144516029-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00402 (612/152338) while in subpopulation AFR AF= 0.0135 (562/41556). AF 95% confidence interval is 0.0126. There are 3 homozygotes in gnomad4. There are 277 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RECQL4 | NM_004260.4 | c.1090G>A | p.Val364Met | missense_variant | 5/21 | ENST00000617875.6 | NP_004251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.1090G>A | p.Val364Met | missense_variant | 5/21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.19G>A | p.Val7Met | missense_variant | 4/20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000524998.1 | c.610G>A | p.Val204Met | missense_variant | 3/4 | 3 | ENSP00000476579.1 | |||
RECQL4 | ENST00000532846.2 | c.-27G>A | upstream_gene_variant | 5 | ENSP00000476551.1 |
Frequencies
GnomAD3 genomes AF: 0.00403 AC: 613AN: 152220Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
613
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00116 AC: 287AN: 247560Hom.: 1 AF XY: 0.000823 AC XY: 111AN XY: 134834
GnomAD3 exomes
AF:
AC:
287
AN:
247560
Hom.:
AF XY:
AC XY:
111
AN XY:
134834
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000463 AC: 676AN: 1459232Hom.: 2 Cov.: 66 AF XY: 0.000423 AC XY: 307AN XY: 725650
GnomAD4 exome
AF:
AC:
676
AN:
1459232
Hom.:
Cov.:
66
AF XY:
AC XY:
307
AN XY:
725650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00402 AC: 612AN: 152338Hom.: 3 Cov.: 33 AF XY: 0.00372 AC XY: 277AN XY: 74492
GnomAD4 genome
AF:
AC:
612
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
277
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
51
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
182
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 29, 2020 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 29, 2022 | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Baller-Gerold syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
PrimateAI
Benign
T
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MVP
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at